Repeated Dose Toxicity Study of a Live Attenuated Oral Cholera Vaccine in Sprague Dawley Rats

Archives of Medical Research

Volumn 40, Issue 7, 2009, Pages 527-535

  Sifontes Rodríguez, Sergio ^a   Infante Bourzac, Juan Francisco ^a   Díaz Rivero, Daiyana ^a   López Feria, Yulieé ^a   Pérez Pérez, Merlin ^a   Sosa Roble, Eligio ^a   Pérez Amat, Viviana ^a   López Hernández, Yamilé ^a   Álvarez Figueredo, Eduardo ^a   Martínez Rodríguez, Juan Carlos ^a   Fariñas Medina, Mildrey ^a   Hernández Salazar, Tamara ^a   Tamayo García, Yolexis ^a   Valdés Abreu, Yolanda ^a   Ponce Collera, Adriana ^a   Rodríguez Pérez, Niurka ^a  

^a FINLAY INSTITUTE   (Cuba)

Author keywords

Live attenuated; Oral; Rat; Repeated dose toxicity; Vaccine; Vibrio cholerae

Indexed keywords

CHOLERA VACCINE; LIVE VACCINE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG SAFETY; FEMALE; FLUID INTAKE; FOOD INTAKE; HEMATOLOGY; INOCULATION; INTERSTITIAL NEPHRITIS; LYMPHOID HYPERPLASIA; MALE; NONHUMAN; ORGAN WEIGHT; PEYER PATCH; RAT; REPEATED DRUG DOSE; SECONDARY IMMUNE RESPONSE; SEX DIFFERENCE; SPRAGUE DAWLEY RAT; TOXICITY TESTING; VIBRIO CHOLERAE;

ANIMALS; CHOLERA; CHOLERA VACCINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; PLACEBOS; PREGNANCY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; VACCINES, ATTENUATED;

EID: 71649100097     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.09.003     Document Type: Article

References (42)

1. World Health Organization. Wkly Epidemiol Rec 2005;80:261-268.
2. Talavera A., Pino Y., Castaño J., et al. Formulation in tablets of a cholera whole cell inactivated vaccine candidate. Vaccine 24 (2006) 3381-3387
3. Benítez J.A., Silva A., García H., et al. Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate. Infect Immun 67 (1999) 539-545
4. Silva A.J., and Benitez J.A. Haemagglutinin/protease expression and mucin gel penetration in El Tor biotype Vibrio cholerae. Microbiology 149 (2003) 1883-1891
5. Viret J.F., and Favre D. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR. Vaccine 22 (2004) 2457-2469
6. García H., Cedré B., Balmaceda T., et al. Selección de cepas atenuadas de Vibrio cholerae para la obtención de candidatos vacunales atenuados orales contra el cólera. Rev Cubana Med Trop 57 (2005) 92-104
7. Sutkowski E. Non-Clinical Safety Assessment of Preventive Vaccines, the FDA Perspective. Proc Workshop on Non-Clinical Safety Evaluation of Preventive Vaccines: Recent Advances and Regulatory Considerations. December 2, 2002; Arlington, VA.
8. Voisin E.M., Collins J.M., and Hoyle P.C. Extrapolation of animal toxicity to humans: interspecies comparisons in drug development. Regul Toxicol Pharmacol 12 (1990) 107-116
9. Human Medicines Evaluation Unit. The European Agency for the Evaluation of Medicinal Products (EMEA). Note for Guidance on Preclinical Pharmacological and Toxicological Testing of Vaccines. London; 17 December 1997. Report No. CPMP/SWP/465/95.
10. Sutkowski E.M. Non-clinical Safety Evaluation of Preventive Vaccines-Regulatory Considerations. Business Briefing: Future Drug Discovery (2003) 34-37
11. World Health Organization. Guidelines on Nonclinical Evaluation of Vaccines. WHO Technical Report Series. Adopted by the 54th meeting of the WHO Expert Committee on Biological Standardization (November 2003) 17-21
12. Thareert K., Potjanee S., and Emsri P. Immunogenicity and protective role of three formulations of oral cholera vaccines. Vaccine 16 (1998) 201-207
13. Kollaritsch H., Cryz Jr. S.J., Lang A.B., et al. Local and systemic immune responses to combined Vibrio cholerae CVD103-HgR and Salmonella typhi ty21a live oral vaccines after primary immunization and reimmunization. Vaccine 18 (2000) 3031-3039
14. Verdier F. Non-Clinical Safety Assessment of Preventive Vaccines, the Industry Perspective. Proceeding of the Workshop on Non-Clinical Safety Evaluation of Preventive Vaccines: Recent Advances and Regulatory Considerations; December 2, 2002; Arlington, VA.
15. Charles River Laboratories, Inc. Charles River Labs-Research Models: Sprague Dawley Rat Informational Resources. http://www.criver.com/research_models_and_services/research_models/SASCO_Sprague_Dawley.html [16 May 2006].
16. National Bio Resource Project for the Rat in Japan (http://www.anim.med.kyoto-u.ac.jp/nbr/strainsx/hematology_list.aspx) [12 April 2006].
17. Pritchett KR. Biology and Medicine of Rats: International Veterinary Information Service, Ithaca, NY; 2004.
18. Taconic Technical Library. Taconic Sprague Dawley Phenotyping. (http://www.taconic.com/addinfo/SD_phenotyping.htm) [12 May 2006].
19. Blumberg D.A., Lewis K., Chatfield P., et al. Pathophysiology of reactions associated with pertussis vaccine. Dev Biol Stand 73 (1991) 289-295
20. Glassroth J. Clinical considerations in designing trials of vaccines for tuberculosis. Clin Infect Dis 30 (2000) S229-S232
21. Kaji M., Kaji M., Ohkuma K., et al. Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382). Vaccine 10 (1992) 663-667
22. Wiersbitzky S., and Reddemann H. Leukemoid reaction or leukosis after MMR preventive vaccination. Kinderarztl Prax 61 (1993) 118-119
23. Soderberg L.S., and Barnett J.B. Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite. Exp Hematol 24 (1996) 848-853
24. Abraham P., Kanakasabapathy I., and Dian B.J. Propylthiouracil attenuates acetaminophen-induced renal damage in the rat. Nephrology 10 (2005) 588-593
25. Aydogdu N., Yalcin O., Batcioglu K., et al. Effects of caffeic acid phenethyl ester on glycerol-induced acute renal failure in rats. Clin Exp Pharmacol Physiol 31 (1998) 575-579
26. Bihorac A., Akoglu E., and Kullu S. Tetracycline-induced acute interstitial nephritis as a cause of acute renal failure. Nephron 81 (1999) 72-75
27. Joh K., Ohkawa K., and Aizawa S. Induction of interstitial nephritis in rats by basement membrane of human origin. Acta Pathol Jpn 39 (1989) 551-557
28. Kamijo Y., Yoshimura K., and Soma K. Effect of milk on intestinal fluid accumulation and renal injury following mercuric chloride ingestion in rats. J Appl Toxicol 24 (2004) 129-134
29. Karahan I., Yilmaz S., Ceribasi A.O., et al. Protective effect of lycopene on gentamicin-induced oxidative stress and nephrotoxicity in rats. Toxicology 215 (2005) 198-204
30. Kitching A.R., Semple T., Li M., et al. Experimental autoimmune anti-glomerular basement membrane glomerulonephritis: a protective role for IFN-gamma. J Am Soc Nephrol 15 (2004) 1764-1774
31. Kumar G., Kannan V., and Pandian M.R. Antihepatotoxic effect of beta-carotene on paracetamol induced hepatic damage in rats. Indian J Exp Biol 43 (2005) 351-355
32. Madhukar R.B. Acute and subchronic (28-day) oral toxicity study in rats fed with novel surfactants. AAPS PharmSci 6 (2004) 1-10
33. Nandi D., and Swarup D. Effect of cysteine, methionine, ascorbic acid and thiamine on arsenic-induced oxidative stress and biochemical alterations in rats. Toxicology 211 (2005) 26-35
34. Sener G., Yuksel M., Gedik N., et al. Hepatic fibrosis in biliary-obstructed rats is prevented by ginkgo biloba treatment. World J Gastroenterol (2005) 5444-5449
35. Senthilkumar S., Manohar B.M., and Babu M.S. Effect of squalene on cyclophosphamide-induced toxicity. Clin Chem Acta 11 (2006) 335-342
36. Sotiriadou S., Mougios V., Ch T., et al. Estrogen effect on some enzymes in female rats after downhill running. Physiol Res 52 (2003) 743-778
37. Tasduq S.A., Gupta D.K., Baleshwar M., et al. Reversal of fibrogenic events in liver by Emblica officinalis (fruit), an Indian natural drug. Biol Pharm Bull 28 (2005) 1304-1306
38. Alsharif N.Z. Protective effects of vitamin A and vitamin E succinate against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced body wasting, hepatomegaly, thymic atrophy, production of reactive oxygen species and DNA damage in C57BL/6J mice. Basic Clin Pharmacol Toxicol 95 (2004) 131-138
39. Chen W., Austin J.W., Shen H., et al. Low dose aerosol infection of mice with virulent type A Francisella tularensis induces severe thymus atrophy and CD4 + CD8+ thymocyte depletion. Microb Pathog 39 (2005) 189-196
40. Ding G., Kapasi A.A., Reddy K., et al. Tubular cell senescence and expression of TGF-beta1 and p21 (WAF1/CIP1) in tubulointerstitial fibrosis of aging rats. Exp Mol Pathol 70 (2001) 43-53
41. Benedetti R., Massouh E., and Flo J. Administration of one dose of cholera toxin induces a systemic immune response prior to a mucosal immune response by a direct presentation in the spleen. Immunol Lett 60 (1998) 149-156
42. Concha A., Castaneda E., Martinez M., et al. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia. Bull Pan Am Health Organ 29 (1995) 312-321